Precancerous cervical lesion in Ethiopia: systematic review and meta-analysis

Table 2 Characteristics of the included studies in the review and meta-analysis, Ethiopia, 2019

Author name	Study year	Region	Method of assessment	HIV status	Study design	Mean age	Response rate (%)	Sample size	Total N outcome	Prevalence (%)	Quality score
Awoke et al. [27]	2017	Amhara	VIA	Both	Cross-sectional	35	100%	428	61	14.3	100
Belayneh et al. [28]	2018	Amhara	Pap smear	HIV	Cross-sectional	34.48	97.60%	284	28	9.9	75
Birra [29]	2016	Addis Ababa	VIA	NS	Cross-sectional	35.73	99%	316	89	28.4	87.5
Gedefaw et al. [30]	2013	SNNPR	VIA	HIV	Cross-sectional	33	98%	448	99	22.1	100
Getinet et al. [31]	2014	Amhara	Pap stain	Both	Cross-sectional	35.02	97.80%	400	56	14.1	100
Hailemariam et al. [32]	2010	SNNPR	Diagnosis logbook	Both	Cross-sectional	41.6	91.70%	2120	350	16.5	87.5
Kassa et al. [33]	2015	Amhara	Women’s chart	HIV	Cross-sectional	35.9	100.00%	435	88	20.2	100
Kebede et al. [34]	2017	Tigray	VIA	Both	Cross-sectional	32.95	100%	342	23	6.7	100
Meseret and Tadiwos [35]	2015	Addis Ababa	VIA	NS	Cross-sectional	35.7	99%	226	54	24.1	100
Netsanet et al. [36]	2014	Addis Ababa	VIA	HIV	Cross-sectional	NR	100%	16632	1663	10	100
Pelzer et al. [37]	1992	Addis Ababa	Cytological investigation	NS	Cross-sectional	NR	90%	2111	33	1.56	62.5
Ruland et al. [38]	2006	SNNPR	Digene HPV test	NS	Cross-sectional	34	100%	189	30	15.9	75
Sami-Ramzi et al. [39]	2006	SNNPR	VIA	NS	Cross-sectional	NR	100.00%	537	93	17.3	100
Teame et al. [40]	2016	Addis Ababa	VIA	Both	Cross-sectional	39.87	95%	360	46	12.8	90
Teka et al. [41]	2017	SNNPR	Women’s chart	Both	Cross-sectional	NR	100%	528	146	27.7	100
Temesgen et al. [42]	2019	Amhara	VIA	Both	Cross-sectional	36.26	100%	422	29	6.9	100
Zewdie et al. [43]	2013	Oromia	VIA	Both	Cross-sectional	32.4	100.00%	334	43	12.9	100

ISSN: 2046-4053